You can be a partner with us by participating in one of our current research studies.
CREDENCE Trial: We are recruiting patients with Type II Diabetes to evaluate if canaglifozin can slow the progression of diabetic nephropathy. For more information, click here or email email@example.com.
ATHENA: We are recruiting Alport Syndrome Patients to study the natural history of kidney disease progression and current standard of care. For more information, click here or email firstname.lastname@example.org.
PEXIVAS: Provincially, we are recruiting patients diagnosed with antineutrophil cytoplasmic autoantibodies (ANCA) vasculitis. The study investigates treatment involving plasma exchange and reduced-dose steroids. For more information, click here or email email@example.com.
For more information regarding different types of clinical studies, reasons to participate and what to expect, please visit the PHSA website.